O-2172

From Wikipedia, the free encyclopedia
Jump to: navigation, search
O-2172
O-2172 structure.png
Systematic (IUPAC) name
methyl 2-cyclopentyl-2-(3,4-dichlorophenyl)acetate
Clinical data
Legal status
?
Identifiers
ATC code ?
PubChem CID 11778793
ChemSpider 9953475 N
Chemical data
Formula C14H16Cl2O2 
Molecular mass 287.181
 N (what is this?)  (verify)

O-2172 is a drug developed by Organix Inc, which acts as a stimulant and potent dopamine reuptake inhibitor. It is an analogue of methylphenidate where the phenyl ring has had a 3,4-dichloro substitution added, and the piperidine ring has been replaced by cyclopentane. It is around 1/3 the potency of methylphenidate, demonstrating that even with the important binding group of the nitrogen lone pair removed entirely, selective DAT binding and reuptake inhibition is still possible.[1][2]

See also[edit]

References[edit]

  1. ^ Meltzer PC, Wang P, Blundell P, Madras BK. Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate. Journal of Medicinal Chemistry. 2003 Apr 10;46(8):1538-45. PMID 12672255
  2. ^ Runyon SP, Carroll FI. Dopamine transporter ligands: recent developments and therapeutic potential. Current Topics in Medicinal Chemistry. 2006;6(17):1825-43. PMID 17017960